GENEVA, Feb. 10 -- EXERIS SA (Via Marconi 46900 Lugano) filed a patent application (PCT/IB2024/057300) for "RECOMBINANT DRA (AFAE) PROTEIN CONJUGATE FOR TREATING TUMORS" on Jul 29, 2024. With publication no. WO/2025/027490, the details related to the patent application was published on Feb 06, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): BADONE, Domenico (c/o EXERIS SAVia Marconi 46900 Lugano), PANZA, Luigi (c/o EXERIS SAVia Marconi 46900 Lugano), MIGGIANO, Riccardo (c/o EXERIS SAVia Marconi 46900 Lugano)
Abstract:
The present invention describes a recombinant DrA (AfaE) protein conjug...